ASHLEY TOY: Open Payments
NPI 1053072850 · GERMANTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 38 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $788 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $219 |
| Novo Nordisk Inc | 4 | $108 |
| Lilly USA, LLC | 5 | $107 |
| ABBVIE INC. | 4 | $83 |
| Exact Sciences Corporation | 3 | $65 |
| Actelion Pharmaceuticals US, Inc. | 1 | $43 |
| PFIZER INC. | 2 | $37 |
| Baxter Healthcare | 1 | $29 |
| Astellas Pharma US Inc | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
Products named: BREZTRI, MOUNJARO, Wegovy, QULIPTA, AIRSUPRA, Cologuard Collection Kit, FARXIGA, OPSYNVI.
Industry payments across MD — which companies pay providers there.
